Evidence-led writing on the molecules, mechanisms and formulation science behind anti-aging and longevity care — for clinicians, pharmacists and partners across the Arab world who value clarity over claims.
Glutamine trials showed a mortality signal in critical illness, a 2024 trial showed amino acid infusion reduces kidney injury after cardiac surgery, and the 2023 taurine anti-aging finding was challenged twice in 2025. A molecule-by-molecule evidence review.
B12 and folate arrive in the IV clinic with better credentials than most infusion ingredients — and the manufacturer's own label advises against the intravenous route. What the methylation cycle does, what the outcome trials settled, and how to read a combined formulation.
Alpha-lipoic acid carries one of the most studied evidence bases of any IV antioxidant — four decades of named trials in diabetic neuropathy. An honest, evidence-graded look at what those trials show, and what the longevity marketing doesn't.
NAD+ IV therapy promises the fastest way to restore cellular energy. Here is what a 2024 head-to-head trial found when IV NAD+ was tested against its own precursor — and an honest look at the mechanism, dosing and safety.
High-dose IV vitamin C floods the bloodstream with concentrations no oral dose can reach. An honest, evidence-graded look at what it does in sepsis, oncology and deficiency — and the safety facts that matter.
Glutathione IV therapy delivers the body's master antioxidant directly into the bloodstream. Mechanism, evidence graded by indication, dosing protocols and the safety facts — for clinicians who need precision, not promises.
What's really in a Myers' cocktail, why it is given by IV, and an evidence-graded look at what it does and doesn't do — exact doses, the one RCT, and the safety facts.
NMN is a precursor; NAD+ is the coenzyme cells use. How the two differ in biochemistry, absorption and human evidence — an evidence-graded comparison for practice.